Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to 0.51.

  • Maravai Lifesciences Holdings' Equity Ratio rose 609.79% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year increase of 609.79%. This contributed to the annual value of 0.57 for FY2024, which is 780.69% up from last year.
  • Maravai Lifesciences Holdings' Equity Ratio amounted to 0.51 in Q3 2025, which was up 609.79% from 0.52 recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Equity Ratio peaked at 0.57 during Q4 2024, and registered a low of 0.16 during Q1 2021.
  • In the last 5 years, Maravai Lifesciences Holdings' Equity Ratio had a median value of 0.4 in 2023 and averaged 0.41.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Equity Ratio soared by 13344.98% in 2021, and later crashed by 248.87% in 2025.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Equity Ratio stood at 0.28 in 2021, then skyrocketed by 39.51% to 0.4 in 2022, then soared by 33.88% to 0.53 in 2023, then rose by 7.81% to 0.57 in 2024, then dropped by 11.17% to 0.51 in 2025.
  • Its Equity Ratio was 0.51 in Q3 2025, compared to 0.52 in Q2 2025 and 0.55 in Q1 2025.